Ranjan Jayanathan
About Ranjan Jayanathan
Executive Vice President and Chief Information Officer at RadNet (also General Manager of eRAD) since 2010; age 69 as of March 31, 2025; electrical engineering degree from MIT. Prior roles include GM of Voyant Health (U.S. operations) and executive management at Dynamic Imaging (led sales, client services, solutions architecture; assisted sale to GE in 2007), plus CIO/R&D positions at Advanced Radiology, Reynolds and Reynolds, and National Medical Computer Services . Company performance context: revenue grew to $1.83B in 2024 (+13.2% y/y) and income from operations reached $104.6M, with compensation programs linked primarily to Adjusted EBITDA and TSR .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Voyant Health | General Manager, U.S. operations | Not disclosed | Led American operations prior to joining RadNet |
| Dynamic Imaging | Executive management (sales, client services, solutions architecture) | Nine years | Helped drive growth; assisted sale to GE in 2007 and integration into GE operations |
| Advanced Radiology | CIO and R&D roles | Not disclosed | Technology leadership in radiology operations |
| Reynolds and Reynolds | CIO and R&D roles | Not disclosed | Enterprise software/process experience applied to healthcare IT |
| National Medical Computer Services | CIO and R&D roles | Not disclosed | Health IT product development and systems |
External Roles
Not disclosed in company filings for this executive .
Fixed Compensation
Not disclosed for this officer; RadNet’s proxies provide detailed compensation only for Named Executive Officers (CEO, CFO, Division Presidents) .
Performance Compensation
Not disclosed for this officer; RadNet’s executive compensation framework emphasizes equity awards (RSUs/PSUs/PSOs/options) and Adjusted EBITDA-based targets for NEOs, with vesting acceleration provisions on death/disability/change-in-control and a clawback policy adopted in November 2023 .
Equity Ownership & Alignment
- Individual beneficial ownership for Mr. Jayanathan is not itemized in the proxy’s ownership table (company lists NEOs/directors individually and all directors/executive officers as a group). Policies prohibit hedging and restrict pledging except with compliance approval and demonstrated financial capacity .
- Group-level ownership snapshot (includes this executive as part of “all directors and executive officers”):
Metric Value Note All directors/executive officers as a group 4,255,064 shares 5.60% of common shares outstanding (14 persons) Options exercisable within 60 days (group) 975,727 shares Liquidity overhang potential Unvested time-based restricted stock (group) 405,180 shares Retention-aligned equity Shares pledged (by another EVP) 177,649 shares Pledging disclosed for Mital Patel; no pledging disclosure for Jayanathan - Insider-trading policy: prohibits hedging/derivatives; pledging only by exception and excluding margin debt, with CFO/Chief Legal Officer oversight .
Employment Terms
- Employment agreements and severance/change-in-control details disclosed for NEOs (and certain executives like the Chief Science Officer and Digital Health President), not for Mr. Jayanathan. Company-level provisions include accelerated vesting of time-based awards upon change-in-control or qualifying termination for NEOs and clawback coverage for senior executives .
Performance & Track Record (Company context relevant to CIO oversight)
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenue ($USD Billions) | 1.43 | 1.62 | 1.83 |
| Adjusted EBITDA ($USD Millions) | 191.28 | 232.30 | 279.46 |
| Net Income ($USD Millions) | 10.65 | 3.04 | 2.79 |
| Cumulative TSR (Base $100) | 92.76 | 171.28 | 344.04 |
Additional qualitative context:
- Expansion, AI investments, and elevated stock-based compensation expense in 2025 tied to higher grant volumes/fair values; RSU/PSU frameworks and grant timing described in filings .
- Equity Incentive Plan authorizes ISOs/NSOs/RSUs/PSUs/PSOs; 20.1M shares reserved; options cannot be repriced without shareholder approval .
Investment Implications
- Retention risk appears contained: 15+ years at RadNet (executive officer since 2010) across CIO and eRAD leadership, with role-critical domain experience in radiology IT and prior M&A integration (Dynamic Imaging → GE). Lack of individualized compensation disclosure limits visibility into vesting calendars and near-term selling pressure for this specific executive, but group-level unvested equity and exercisable options suggest ongoing retention incentives across the team .
- Alignment safeguards: hedging prohibitions and restricted pledging reduce misalignment risk; clawback policy covering senior executives mitigates accounting/misconduct risk. Overall compensation design (Adjusted EBITDA/TSR emphasis) and strong 2022–2024 revenue/Adjusted EBITDA trajectory support pay-for-performance linkage, though the absence of Jayanathan-specific metrics necessitates monitoring Form 4s and future proxies for award details and ownership updates .